641-57-6

Basic information

• Product Name: 7,9-Diphenyl-8H-cyclopent[a]acenaphthylen-8-one
• Synonyms: 7,9-Diphenyl-8H-cyclopent[a]acenaphthylen-8-one;Acecyclone;7,9-diphenyl-8H-cyclopenta[a]acenaphthylen-8-one
• CAS NO: 641-57-6
• Molecular Formula: C₂₇H₁₆O
• Molecular Weight: 356.4153
• Mol File: 641-57-6.mol
• Article Data: 29

Chemical Properties

• Melting Point: 289 °C
• Boiling Point: 660.9°Cat760mmHg
• Flash Point: 291.6°C
• Appearance: /
• Density: 1.32g/cm³
• Vapor Pressure: 2.44E-17mmHg at 25°C
• Refractive Index: 1.767
• CAS DataBase Reference: 7,9-Diphenyl-8H-cyclopent[a]acenaphthylen-8-one(CAS DataBase Reference)
• NIST Chemistry Reference: 7,9-Diphenyl-8H-cyclopent[a]acenaphthylen-8-one(641-57-6)
• EPA Substance Registry System: 7,9-Diphenyl-8H-cyclopent[a]acenaphthylen-8-one(641-57-6)

Safety Data

• Hazardous Substances Data: 641-57-6(Hazardous Substances Data)

Usage

General Description

7,9-Diphenyl-8H-cyclopent[a]acenaphthylen-8-one is a chemical compound with the molecular formula C24H18O. It is a heterocyclic organic compound with a unique structure, consisting of a cyclopentene ring fused to an acenaphthylene ring with two phenyl groups attached to the 7th and 9th positions. 7,9-Diphenyl-8H-cyclopent[a]acenaphthylen-8-one is most commonly used as a building block in organic synthesis, particularly in the preparation of pharmaceuticals, agrochemicals, and other specialty chemicals. Its specific properties and uses are largely dependent on the functional groups attached to the molecule, making it a versatile and valuable intermediate in chemical reactions. Additionally, research has shown that this compound possesses potential biological activities, such as anti-inflammatory and antiproliferative properties, making it of interest in medicinal chemistry.

InChI:InChI=1/C27H16O/c28-27-23(18-9-3-1-4-10-18)25-20-15-7-13-17-14-8-16-21(22(17)20)26(25)24(27)19-11-5-2-6-12-19/h1-16H

Upstream product

• 82-86-0 acenaphthene quinone 
• 102-04-5 1,3-Diphenylpropanone 
• 103-82-2 phenylacetic acid 
• 82881-01-4 9-dicyanomethylene-8,10-diphenyl-7-(1-pyrrolidinyl)-9H-cycloocta<1,2,3-ij>naphthalene 
• 64-17-5 ethanol 
• 64-19-7 acetic acid 
• 110-86-1 pyridine 
• 17694-87-0 1,8-bis-(phenylethynyl)naphthalene 
• 70109-15-8 1-(1-pyrrolidinyl)acenaphthylene 
• 886-38-4 diphenylcyclopropenone 
• 92050-53-8 2-(2-Oxo-1a,3-diphenyl-1a,2-dihydro-1-aza-cyclopropa[1,5]cyclopenta[1,2-a]acenaphthylen-1-yl)-isoindole-1,3-dione 
• 82873-06-1 2-(7,9-diphenyl-8H-cyclopenta[a]acenaphthylen-8-ylidene)malononitrile 
• 108060-79-3 1-phenyl-2-<8-(phenylethynyl)-1-naphthyl>cyclopropenone 
• 201230-82-2 carbon monoxide 

Downstream Products

• 745018-17-1 7,10-diphenyl-fluoranthene-8,9-dicarboxylic acid-anhydride 
• 55087-78-0 7,10-diphenylfluoranthene 
• 120908-33-0 (+/-)-7,13-diphenyl-(7ar,12ar)-7a,12a-dihydro-12H-indeno[1,2-k]fluoranthene 
• 7229-88-1 7,14-diphenylacenaphthol[1,2-k]-fluoranthene 
• 23532-19-6 7.10-Diphenyl-8-(1-hydroxy-1-ethyl-propyl)-fluoranthen 
• 29769-79-7 C₅₅H₃₆O 
• 29079-02-5 8-Biphenyl-4-yl-7,10-diphenyl-fluoranthene 
• 23353-84-6 7.10-Diphenyl-8-(cyclohexyl-hydroxymethyl)-fluoranthen 
• 30122-19-1 C₃₀H₂₀O 
• 22994-51-0 7.10-Diphenyl-8-<9-hydroxy-fluorenyl-(9)>-fluoranthen 
• 29079-08-1 2-Biphenyl-4-yl-3-biphenyl-4-ylethynyl-1,4-diphenyl-triphenylene 
• 29219-90-7 C₆₈H₄₂ 
• 60824-73-9 8-Benzyliden-7,9-diphenyl-8H-cyclopentacenaphthylen 
• 60824-75-1 8-(2,4-Dichlorbenzyliden)-7,9-diphenyl-8H-cyclopentacenaphthylen 

Relevant articles and documents

7, 11- diphenyl-8H- acenaphth[1, 2- f] isoindole- 8, 10 (9H) - Dione functionalized polysiloxane with aggregation-induced emission: Synthesis and highly sensitive detection for Fe3+

Fluorescent silicone polymers have attracted much attention owing to their strong fluorescence and high stabilities. However, most of these silicone polymers have suffered from fluorescence quenching caused by aggregation in high concentrations. In this w

CARBON MONOXIDE-RELEASING MOLECULES AND THERAPEUTIC APPLICATIONS THEREOF

Carbon monoxide-releasing organic molecules are described herein. The molecules can be synthesized prior to administration (e.g., ex vivo) or formed in vivo. In those embodiments where the molecules are formed in vivo, reactants are administered under physiological conditions and undergo a cycloaddition reaction to form a product which releases carbon monoxide. In applying such reactions for therapeutic applications in vivo, the cycloaddition and CO release typically occur only under near-physiological or physiological conditions. For example, in some embodiments, the cycloaddition reaction and/or release of carbon monoxide occur at a temperature of about 37° C and pH of about 7.4. Pharmaceutical compositions and methods for release carbon monoxide are also described.

Benzofluoranthene compound and an organic electronic device including the same (by machine translation)

The specification describes, organic electronic element life, efficiency, electric and thermal stability, chemical stability is greatly improved and novel Benzofluoranthene compound contained in the organic compound layer compd. org. electronic element. (